COUNTERPOINT: INTERLEUKIN-6 DOES NOT HAVE A BENEFICIAL ROLE IN INSULIN SENSITIVITY AND GLUCOSE HOMEOSTASIS
Open Access
- 1 February 2007
- journal article
- editorial
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 102 (2), 816-818
- https://doi.org/10.1152/japplphysiol.01208a.2006
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant SubjectsJournal of Biological Chemistry, 2003
- Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in HepatocytesJournal of Biological Chemistry, 2003
- SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2Journal of Biological Chemistry, 2002
- Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight LossJournal of Clinical Endocrinology & Metabolism, 2000
- Interleukin 6 and liver regenerationGut, 2000
- Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetesLife Sciences, 2000
- Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin-stimulated glycogen synthesis in rat hepatocytesHepatology, 1998
- Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide TreatmentDiabetes Care, 1998
- Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by GlucocorticoidJournal of Clinical Endocrinology & Metabolism, 1998
- Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor- , in VivoJournal of Clinical Endocrinology & Metabolism, 1997